HIMS up 48% in a week. However they are not done yet

Besides GLP-1, their other revenue lines are growing.
https://www.reddit.com/r/HIMS/

Just looking at the hair loss product results, it is quite amazing.

I would say they are in a good position to legitimize some of the peptides. Right now, it is a grey market; you are buying from some unknown compounder in China. While it is cheap and looks like it works, I believe people will pay a premium to buy from an American brand.

Another main focus is their overseas adoption. They bought Eucalyptus, which is the market leader in Australia, the UK, and Germany. They are also expanding into Japan and Canada. If they can duplicate their model overseas, that will be a huge subscription gain.

The next earning call might pull them back a bit as their revenue will be hurt as they can't sell GLP-1 compound, however long term, if they execute as planned, i can see them at least going back to $70